Utang jangka cendhak marang modal Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Corp - logo grafis emiten LEXX

Lexaria Bioscience (LEXX) leverages the expertise of dedicated DehydraTECH specialists, ensuring zero churn among key developers. The business is striving for patent superiority within the lipid delivery systems niche, where the risk of losing licensing payments stands at 0.01. The price trend on GURU.Markets complements data regarding production environmental optimization and the implementation of ESG standards to reduce industrial waste.

Rasio tanggungan utang jangka cendhak marang modal lexariabioscience.com (LEXX): kanggo periode 04.07.2022 - 28.10.2026

Rincian metrik lan analitis perusahaan Lexaria (LEXX)

- rega lan prakiraan konsensus rega:
Rega saham Lexaria Bioscience|LEXX - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar Lexaria Bioscience Corp|LEXX - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Lexaria Bioscience|LEXX - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku lexariabioscience.com|LEXX - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Lexaria Bioscience|LEXX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Lexaria Bioscience|LEXX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Lexaria Bioscience Corp
Analisis umum perusahaan:Lexaria Bioscience Corp. (LEXX)
Produk merek lexariabioscience.com

Logistics optimization for drug delivery at Lexaria Bioscience (LEXX) directly impacts the ratio of short-term borrowing to equity, reflecting the dependence of operating profitability on external financing. This metric compares liabilities with maturities exceeding one year against equity, allowing investors to assess the risk of cash flow gaps during the scaling of pharmaceutical raw material procurement and the issuer's overall debt sustainability.

Pesaing Lexaria Bioscience

Haleon Group (HLN) - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal Kenvue Health (KVUE)|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|jyongbio.com - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Ligand (LGND)|AMRX: Rasio tanggungan utang jangka cendhak marang modal|PRGO (Perrigo Company) - Utang jangka cendhak marang ekuitas|Alvotech Biopharmaceuticals (ALVO) - Rasio utang jangka cendhak marang ekuitas|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal MNKD (MannKind Corp)|AMPH: Utang jangka cendhak marang ekuitas|PCRX - Kewajiban jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ARS Pharmaceuticals SPRY|TBPH - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang modal Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal TECX (Tectonic Therapeutic Inc.)|Kewajiban jangka cendhak marang modal TNXP|China SXT Pharmaceuticals (SXTC) - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal EPRX (eupraxiapharma.com)|Utang jangka cendhak marang ekuitas BioHarvest Sciences Inc. BHST|Utang jangka cendhak marang ekuitas Invizyne Technologies EXOZ|ORMP (Oramed Pharma) - Utang jangka cendhak marang modal|Entera Bio Ltd. (ENTX) - Kewajiban jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas MindWalk Holdings|abvcpharma.com (ABVC) - Rasio utang jangka cendhak marang modal|CPIX (Cumberland Pharmaceuticals Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal QNTM|FibroGen Corp (FGEN) - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Telomir Pharmaceuticals Corp (TELO)|Utang jangka cendhak marang modal RANI|Koefisien utang jangka cendhak marang modal Synergy CHC Corp. SNYR|Rallybio Corp. - Utang jangka cendhak marang modal|Pulmatrix Inc (PULM) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ftzy.com.cn PTHL|Aptorum Group (APM) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal Lyra Therapeutics, Inc.|Utang jangka cendhak marang ekuitas impactbiomedinc.com|TNFA (TNF Pharmaceuticals) - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal YCBD (cbdmd.com)|PRFX: Utang jangka cendhak marang ekuitas|Altamira Therapeutics Ltd - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas LIPO (Lipella Pharmaceuticals)|OPTN - Koefisien utang jangka cendhak marang modal|PIRS (Pieris Pharmaceuticals, Inc.) - Utang jangka cendhak marang modal|Procaps Group (PROC) - Rasio utang jangka cendhak marang ekuitas|PTPI: Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Qilian International Corp|Acelyrin, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal TFFP (tffpharma.com)